DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Age-Dependent Memory Benefits From Pharmacologically Enhanced Naps?

Information source: University of California, San Diego
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Older Adults

Intervention: Sodium Oxybate (Drug); Zolpidem (Drug); placebo (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: University of California, San Diego

Overall contact:
Jen Kanady, BA, Phone: 858-642-3192, Email: jkanady@vapop.ucsd.edu

Summary

The purpose of this study is to investigate whether

1. pharmacologically enhanced naps will show increases in specific sleep stages

2. whether these sleep stages will produces specific increases on memory tests

3. whether older adults will benefit more than young adults from increased SWS or Stage 2 on subsequent declarative and motor memory tests.

Clinical Details

Study design: N/A

Eligibility

Minimum age: 60 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- English-speaking individuals, half men and half women, and between the ages of 60 and

75 years will be recruited. No ethnic group will be specifically excluded from study. All participants will be recruited from general San Diego Community. An education requirement of at least 12 years completed will be imposed, as education may affect performance on the cognitive task.

Exclusion Criteria:

- Not having a regular sleep-wake schedule (defined as not meeting criteria listed

above and/or a Horne-Ostberg Morningness-Eveningness Questionnaire score not between 31-69)

- Having a sleep disorder (reported or detected on the questionnaires)

- Any personal or immediate family (i. e., first degree relative) history of diagnosed

significant psychopathology

- Personal history of head injury with loss of consciousness greater than 15 minutes or

seizures

- History of substance dependence

- Current use of any psychotropic medications

- Any cardiac, respiratory or other medical condition which may affect cerebral

metabolism

- Given the nature of the stimulus and its presentation, anyone with non-correctable

vision and audition impairments will also be excluded.

Locations and Contacts

Jen Kanady, BA, Phone: 858-642-3192, Email: jkanady@vapop.ucsd.edu

Laboratory for Sleep and Behavioral Neuroscience, La Jolla, California 92093, United States; Recruiting
Jen Kanady, BA, Phone: 858-642-3192, Email: jkanady@vapop.ucsd.edu
Additional Information

Starting date: October 2008
Last updated: October 15, 2008

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009